link: http://ift.tt/1MJldsy
Hot And Trending...
Trending
- March report "How Revolutions, Wars and Plagues are Harbingers of 'Great Changes' in Societies and in Economics" published. http://bit.ly/2y4LJZQ
- Steve Wynn says deficit spending is “degrading” America’s standard of living. See what he says about the debates: https://t.co/nXr3r30CWN
- Somaliland's Private Sector at a Crossroads
- If This Is a Recovery, We Don't Want to See the Next Downturn @SchiffGold http://t.co/p92k7yR23d
- Would you let your cat play with a 9 grand on a ball of yarn? http://bit.ly/2ArHoQ7
- All Izz Well [Full HD Song] 3 Idiots izle
- VOXEU: Leveraged bubbles
- Dow Jones down 6% from its highs & falling fast. How much more will it fall before the Fed stops pretending the data supports a rate hike?
- When the next recession hits, the Fed will cancel plans for tightening, & it may even throw in a few bailouts. http://bit.ly/2iM0oFA
- Review of Matt Ridley's new book "The Evolution of Everything: How New Ideas Emerge" from an 'Austrian Economics'/Hayekian perspective
Wednesday, September 23, 2015
I'm sure you've heard of Daraprim, the drug whose price skyrocketed recently...
...After the rights to sell it under that name were bought. What I'm wondering is why the price has skyrocketed without significant government intervention. Or is the right to sell under that name enough to keep competition out? Seems implausible. Presumably, competition would decrease the price, so what's keeping entrants from the market?